Medical XpressHigh-Dose Vitamin D May Improve Cognition Among Those at Risk of Dementia, Study Finds

⚠️ Small Study / Early Comparative Evidence

Researchers evaluated 54 adults with both mild cognitive impairment (MCI) and sleep disturbances, a population considered at elevated risk for progression to dementia. Participants reporting vitamin D intake of at least 5,000 IU daily scored more than 13% higher on the Montreal Cognitive Assessment (MoCA) compared with those not taking vitamin D after adjustment for other variables.

Clinical Considerations

• The observed relationship was an association rather than evidence of causation.
• Benefits were observed only among participants reporting intake of at least 5,000 IU daily.
• Cognitive performance did not differ by vitamin D subtype (D2 vs D3).
• The study focused on a specific high-risk population with both MCI and sleep disturbance.
• Small sample size limits certainty and generalizability.
• Consistent with HCN nutrition/vitamin standards, vitamin D should be viewed as risk-context evidence rather than intervention guidance. Associations do not establish treatment benefit.

Practice Applications

• Reinforces interest in potentially modifiable factors associated with cognitive health among adults with MCI and sleep disruption.
• May inform future studies examining nutritional status, sleep health, and cognitive trajectories.
• Findings do not support changing clinical management or supplement recommendations based on this study alone.
• Results are best viewed as hypothesis-generating pending larger prospective trials.